Cellid Co., Ltd.   Report issue

For profit Phase 1 Phase 2
Founded: Seoul Korea, Republic of (2006)

Organization Overview

First Clinical Trial
2016
NCT02866006
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Cellid Co., Ltd.